Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations.
about
Cisplatin in 5% Ethanol Eradicates Cisplatin-Resistant Lung Tumor by Killing Lung Cancer Side Population (SP) Cells and Non-SP Cells.Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapyMagnetically Targeted Nanocapsules for PAA-Cisplatin-Conjugated Cores in PVA/SPIO Shells via Surfactant-Free Emulsion for Reduced Nephrotoxicity and Enhanced Lung Cancer Therapy.Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids.
P2860
Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations.
@ast
Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations.
@en
type
label
Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations.
@ast
Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations.
@en
prefLabel
Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations.
@ast
Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations.
@en
P2093
P2860
P356
P1476
Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations.
@en
P2093
Alan Tsang
David Bermudes
Lawrence Mayer
Nancy Dos Santos
Natalia Zisman
Paul Tardi
Sharon Johnstone
P2860
P304
P356
10.1155/2011/213848
P577
2011-01-24T00:00:00Z